FWSM
TRIB

First Wilshire Securities Management’s Trinity Biotech TRIB Stock Holding History

First Wilshire Securities Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,531
Closed -$547K – 96
2019
Q4 		$547K Sell
3,531
-1,623
-31% -$232K 0.21% 63
2019
Q3 		$935K Sell
5,154
-141
-3% -$36.7K 0.35% 50
2019
Q2 		$1.31M Sell
5,295
-1,246
-19% -$445K 0.52% 49
2019
Q1 		$2.8M Sell
6,541
-57
-0.9% -$23.5K 0.95% 38
2018
Q4 		$2.27M Sell
6,598
-198
-3% -$91.7K 0.85% 38
2018
Q3 		$4.08M Sell
6,796
-76
-1% -$49.5K 1.2% 31
2018
Q2 		$5.15M Buy
6,872
+200
+3% +$144K 1.54% 25
2018
Q1 		$5.16M Sell
6,672
-172
-3% -$141K 1.43% 27
2017
Q4 		$5.24M Sell
6,844
-275
-4% -$213K 1.43% 28
2017
Q3 		$5.99M Sell
7,119
-77
-1% -$64.4K 1.7% 22
2017
Q2 		$6.48M Buy
7,196
+28
+0.4% +$23.8K 1.85% 18
2017
Q1 		$6.41M Buy
7,168
+1,278
+22% +$1.2M 1.85% 18
2016
Q4 		$6.11M Buy
+5,890
New +$6.09M 1.75% 20

Other funds holding TRIB

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

First Wilshire Securities Management's TRIB Position: Q1 2020 in Review

First Wilshire Securities Management sold out of Trinity Biotech (TRIB) in Q1 2020, closing a stake of 3,531 shares — an estimated $547K sold.

First Wilshire Securities Management first reported a position in TRIB in Q4 2016 and held it in 13 quarters. The position peaked at $6.48M in Q2 2017. 22 funds tracked by Wall St. Rank hold TRIB as of Q1 2020.

  • First Wilshire Securities Management reported no remaining Trinity Biotech position as of Q1 2020 after selling out during the quarter.
  • First Wilshire Securities Management sold 3,531 Trinity Biotech shares in Q1 2020, an estimated $547K.
  • First Wilshire Securities Management first reported a position in Trinity Biotech in Q4 2016 and held it in 13 quarters.
  • First Wilshire Securities Management's Trinity Biotech position peaked at $6.48M in Q2 2017.
  • 22 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2020.

Based on First Wilshire Securities Management's 13F filing for Q1 2020, filed 15 May 2020.